Cisplatin combinations in cervical cancer—which is best?

DO Holtz, CJ Dunton - Nature Reviews Clinical Oncology, 2010 - nature.com
DO Holtz, CJ Dunton
Nature Reviews Clinical Oncology, 2010nature.com
We reviewed the results of the Gynecological Oncology Group 204 (GOG-204) randomized
phase III trial, which investigated four cisplatin combination chemotherapy regimens for the
treatment of patients with recurrent or metastatic cervical carcinoma. As the overall survival
was similar between all arms, treatment recommendations need to be tailored based on
toxic effects.
We reviewed the results of the Gynecological Oncology Group 204 (GOG-204) randomized phase III trial, which investigated four cisplatin combination chemotherapy regimens for the treatment of patients with recurrent or metastatic cervical carcinoma. As the overall survival was similar between all arms, treatment recommendations need to be tailored based on toxic effects.
nature.com